0001225208-16-023457.txt : 20160105 0001225208-16-023457.hdr.sgml : 20160105 20160105161101 ACCESSION NUMBER: 0001225208-16-023457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160101 FILED AS OF DATE: 20160105 DATE AS OF CHANGE: 20160105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bose Supratim CENTRAL INDEX KEY: 0001538431 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 161322212 MAIL ADDRESS: STREET 1: 11A COOLING CLOSE CITY: SINGAPORE STATE: U0 ZIP: 558176 4 1 doc4.xml X0306 4 2016-01-01 0000885725 BOSTON SCIENTIFIC CORP BSX 0001538431 Bose Supratim 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP & President, Asia-Pacific Common Stock 2016-01-01 4 M 0 34302.0000 0.0000 A 150697.0000 D Common Stock 2016-01-03 4 M 0 14926.0000 0.0000 A 165623.0000 D Performance Share Units 2016-01-01 4 M 0 34302.0000 0.0000 D 2015-12-31 2015-12-31 Common Stock 34302.0000 0.0000 D Deferred Stock Units 2016-01-03 4 M 0 14926.0000 0.0000 D Common Stock 14926.0000 14926.0000 D On February 28, 2013, the reporting person was awarded a target number of performance share units under the Company's 2013 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2013 adjusted free cash flow measured against its 2013 financial plan over the one-year performance period ending December 31, 2013 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2015. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on January 3, 2013, the first anniversary of the date of grant. /s/ Lee G. Giguere, Attorney-in-Fact 2016-01-05